Medivis Report issue

For profit
Founded: New York NY United States (2016)

Organization Overview

First Clinical Trial
2019
NCT04536129
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Medivis

Active Ingredients

Drugs in Other Trials (1)

hydrocortisone (solu-cortef) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1